search
Back to results

Randomized Controlled Trial on Cardiovascular Exercise in Uncontrolled Epilepsy: (Epilepsy)

Primary Purpose

Refractory Epilepsy

Status
Terminated
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Exercise
Relaxation
Sponsored by
Vastra Gotaland Region
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Refractory Epilepsy focused on measuring Cardiovascular fitness, refractory epilepsy,

Eligibility Criteria

16 Years - 65 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age 16 years to 65 years
  2. An established diagnosis of focal epilepsy
  3. A frequency of at least 3 focal seizures (including focal to bilateral tonic-clonic) during a 4 week-prospective baseline, despite ongoing treatment with one to 4 AEDs
  4. Stable AED treatment for at least 4 weeks, and no expected need to modify current AED treatment over the subsequent 6 months.
  5. Capability to follow instructions (or has a caretaker who will help) and keep a seizure calendar
  6. Ability to understand the purpose, procedures and potential risks and benefits associated with participation in the study;
  7. Willingness to give freely written informed consent

Exclusion Criteria:

  1. Any associated condition contraindicating non-competitive physical exercise
  2. Patients already engaged in regular daily physical exercise program;
  3. A history of seizures induced by exercise
  4. A history of psychogenic non-epileptic seizures
  5. Pregnancy or puerperium
  6. Alcohol or substance abuse
  7. Any condition (for example, an unstable or progressive medical condition) which, in the investigator's assessment, may interfere with the evaluation procedures or the objectives of the study

Sites / Locations

  • Elinor Ben-Menachem

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Exercise

Relaxation

Arm Description

Use of an ergometric bicycle where patients will bicycle 5 Days a week for 20 minutes at a predetermine level

Patients will listen to a relaxation exercise involving muscle relaxation. This takes about 20 minutes and will be performed 5 Days/week

Outcomes

Primary Outcome Measures

Proportion of patients with at least 50% seizure reduction
Determined by seizure diary

Secondary Outcome Measures

Change in anxiety and depression ratings
Reduction in Hospital Anxiety and Depression Scale (HAD) scores.The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3. A total score can be between 0 and 21 for either anxiety or depression. A lower score indicates less depression or anxiety: a cut-off point of 8/21 indicates the presence of anxiety or depression
Change in Health-Related Quality of Life
Improvement in "RAND-36 -Measure of Health Related Quality of Life" version called Item Health Survey (Version 1.0) score. There are 8 domains with 36 items in total. The eight health concepts are: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain and general health perceptions. All items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In a second step, items in the same scale are averaged together to create the 8 scale scores. Scores represent the percentage of total possible score achieved.
Reduction in adverse event reporting
Subjective reporting by patient
Median percent change in seizure frequency
Seizure Counts by seizure diary

Full Information

First Posted
May 28, 2018
Last Updated
November 5, 2021
Sponsor
Vastra Gotaland Region
search

1. Study Identification

Unique Protocol Identification Number
NCT03570489
Brief Title
Randomized Controlled Trial on Cardiovascular Exercise in Uncontrolled Epilepsy:
Acronym
Epilepsy
Official Title
Randomized Controlled Study of the Effect of Cardiovascular Exercise in Uncontrolled Epilepsy: Efficacy, Side Effects and Quality of Life
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Terminated
Why Stopped
Could not recruit patients because of Covid 19 restrictions and because of lack of efficacy for primary endpoint
Study Start Date
November 30, 2018 (Actual)
Primary Completion Date
October 6, 2021 (Actual)
Study Completion Date
October 6, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vastra Gotaland Region

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is an open-label randomized controlled tria testing if an improvement in cardiovascular fitness can improve quality of Life and reduce seizure frequency in patients with refractory epilepsy.. Before the intervention each subject will undergo an evaluation of baseline cardiovascular fitness. Patients will be randomized into two groups One group will listen to a relaxation tape 5 days per week for 6 months and the other group will receive a ergometric cycle and perform a predetermined level of exercise per day , 5 days per week for 6 months. Randomization will be conducted an external randomization center based on a sequence of random numbers. Changes in concomitant antiepileptic drugs (AED) treatment during the study will be minimized, and restricted to AED changes deemed to be necessary to address AED-related toxicity. Medical examination; body weight; fitness test, including ECG and BP measurements, seizure frequency; adverse effects (unstructured interview); details of concomitant concomitant treatment, mood assessment by using the Hospital Anxiety and Depression Scale-Anxiety (HADS); health related quality of life (RAND-36), E4-data downloading, will be done at baseline and after 6 months Primary endpoint: Proportion of patients with at least 50% seizure reduction Secondary endpoints: Median percent reduction in seizure frequency, HADS score, RAND-36 score, fitness score; adverse events, changes in concomitant AED treatment, E4 data .
Detailed Description
Objectives The primary objective of this study is to assess the effect of a 6-month course of standardized physical exercise, added on to pre-existing stable AED treatment, on seizure frequency in patients with epilepsy aged 16 to 65. Secondary objectives include the assessment of the effect of a 6-month course of standardized physical exercise, added on to pre-existing stable AED treatment, on (i) depressive and anxiety symptom scores; (2) health-related quality of life; (3) adverse events. Study design Open-label randomized controlled trial. Before the intervention each subject will undergo an evaluation of cardiovascular fitness using the cycle ergometric test and his/her work level ((Wmax/kg) transformed into a stanine (1-9) score. Patients will be randomized into two groups by applying a stratification procedure which will allow a similar proportion of patients with high fitness (stanine score 5 to 9) and low fitness (stanine score 1 to 4) in both groups. Randomization will be conducted by telephone through an external randomization center based on a sequence of random numbers. Of the two randomized groups, one (Intervention group) will receive a course of standardized physical exercise for at least 5 days per week while the other group (control group) will randomize to listening to a computerized disc (CD) on muscular relaxation.. Changes in concomitant AED treatment during the study will not be allowed unless for adverse events related to the AEDs. Study procedures Patients considered to be eligible for the study will undergo initially a 4-week prospective baseline to ascertain baseline seizure frequency. After confirming their eligibility based on seizure frequency recording, patients will be examined by a study physician and by a physical therapist who will conduct an ergonomic test with a stationary bicycle under ECG and blood pressure monitoring to determine the level of cardiovascular fitness required for stratification. Thereafter the patients will be randomized to the intervention and the control group. The intervention group will receive a course of standardized physical exercise designed to fulfill the Swedish recommendations (FYSS) on exercise for disease-prevention (150 min per week of average intensity); at least 5 days per week for 6 months using a bicycle ergometer for 30 minutes a day. An individually adjusted workload will be determined by the physical therapist to achieve moderate intensity workout based on maximal oxygen uptake (VO2)max and percentage of maximal heart rate. Patients in the other group (control group) will be randomized to listen to a CD on muscular relaxation every day for 20 minutes and continue with their usual lifestyle. At enrollment, subjects randomized to the intervention group will be provided with a bicycle ergometer. requirements) as well parameters related to seizure activity. The following evaluations will be conducted at the times indicated, which correspond to hospital visits: Time 0 (enrollment): Medical examination; body weight; fitness test (Åstrand submax test, which is a submaximal test of aerobic fitness.), including ECG and BP measurements, seizure frequency (last 4 weeks); adverse effects (unstructured interview); details of concomitant concomitant treatment, mood assessment by using the Hospital Anxiety and Depression Scale-Anxiety (HADS); health related quality of life (RAND-36). Month 1, 2, 3, 4 and 5: Seizure frequency (recorded daily on seizure calendars), adverse effects (unstructured interview); body weight; details of concomitant treatment, E4-data downloading, advice on exercise from physical therapist. Month 6: Medical examination; body weight; fitness test, including ECG and BP measurements, seizure frequency; adverse effects (unstructured interview); details of concomitant concomitant treatment, mood assessment by using the Hospital Anxiety and Depression Scale-Anxiety (HADS); health related quality of life (RAND-36), E4-data downloading, Any additional testing (e.g. EEG, laboratory tests) may be performed as considered clinically indicated by the treating physician. Sample size and statistical analysis Assuming that 40% of patients in the intervention group vs. 20% of patients in the control group have a 50% or greater reduction in seizure frequency compared with baseline, 79 patients per group provide 80% power to identify a difference between groups at a significance level of 0.05. To account for potential dropouts, a total of 100 patients per group will be randomized. The primary analysis will be intent-to-treat (ITT) using "The Last Observation Carried Forward " (LOCF) extrapolation when appropriate. Per-protocol analysis (PPT) will exclude patients discontinuing prematurely the study and patients with less than 75% compliance with exercise requirements. Ethical aspects The study protocol has been approved by the Ethics Committees of Gothenburg in behalf of the participating centers. Before the study, all patients will be informed about the objectives and implications of the study, and will be asked to sign an informed consent form.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Refractory Epilepsy
Keywords
Cardiovascular fitness, refractory epilepsy,

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Open label randomized parallel design
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Exercise
Arm Type
Active Comparator
Arm Description
Use of an ergometric bicycle where patients will bicycle 5 Days a week for 20 minutes at a predetermine level
Arm Title
Relaxation
Arm Type
Sham Comparator
Arm Description
Patients will listen to a relaxation exercise involving muscle relaxation. This takes about 20 minutes and will be performed 5 Days/week
Intervention Type
Behavioral
Intervention Name(s)
Exercise
Other Intervention Name(s)
cardiovascular fitness
Intervention Description
Patients will bicycle for 20 minutes per day for 5 days per week for 6 months
Intervention Type
Behavioral
Intervention Name(s)
Relaxation
Intervention Description
Patients will listen to a relaxation tape 20 minutes per day 5 Days a week for 6 months
Primary Outcome Measure Information:
Title
Proportion of patients with at least 50% seizure reduction
Description
Determined by seizure diary
Time Frame
Change from baseline at 6months
Secondary Outcome Measure Information:
Title
Change in anxiety and depression ratings
Description
Reduction in Hospital Anxiety and Depression Scale (HAD) scores.The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3. A total score can be between 0 and 21 for either anxiety or depression. A lower score indicates less depression or anxiety: a cut-off point of 8/21 indicates the presence of anxiety or depression
Time Frame
Change from Baseline at 6 months
Title
Change in Health-Related Quality of Life
Description
Improvement in "RAND-36 -Measure of Health Related Quality of Life" version called Item Health Survey (Version 1.0) score. There are 8 domains with 36 items in total. The eight health concepts are: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain and general health perceptions. All items are scored so that a high score defines a more favorable health state. In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. In a second step, items in the same scale are averaged together to create the 8 scale scores. Scores represent the percentage of total possible score achieved.
Time Frame
Change from Baseline at 6 months
Title
Reduction in adverse event reporting
Description
Subjective reporting by patient
Time Frame
Improvement from baseline at 6 months
Title
Median percent change in seizure frequency
Description
Seizure Counts by seizure diary
Time Frame
Change from Baseline at 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 16 years to 65 years An established diagnosis of focal epilepsy A frequency of at least 3 focal seizures (including focal to bilateral tonic-clonic) during a 4 week-prospective baseline, despite ongoing treatment with one to 4 AEDs Stable AED treatment for at least 4 weeks, and no expected need to modify current AED treatment over the subsequent 6 months. Capability to follow instructions (or has a caretaker who will help) and keep a seizure calendar Ability to understand the purpose, procedures and potential risks and benefits associated with participation in the study; Willingness to give freely written informed consent Exclusion Criteria: Any associated condition contraindicating non-competitive physical exercise Patients already engaged in regular daily physical exercise program; A history of seizures induced by exercise A history of psychogenic non-epileptic seizures Pregnancy or puerperium Alcohol or substance abuse Any condition (for example, an unstable or progressive medical condition) which, in the investigator's assessment, may interfere with the evaluation procedures or the objectives of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elinor Ben-Menachem, MD,PhD
Organizational Affiliation
University of Gothenburg, Department of Clincial Neuroscience, Sahlgrenska Academy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Elinor Ben-Menachem
City
Göteborg
State/Province
Västra Götaland
ZIP/Postal Code
41345
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
The plan is to share but we are uncertain just now as to how

Learn more about this trial

Randomized Controlled Trial on Cardiovascular Exercise in Uncontrolled Epilepsy:

We'll reach out to this number within 24 hrs